Company Name, Ticker, Industry, else..

Allergan plc (NYSE: AGN)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Allergan Plc's

Name: Allergan Plc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AGN Sales vs. its Competitors Q1 2020

Comparing the current results to its competitors, Allergan Plc reported Revenue increase in the 1 quarter 2020 by 0.2 % year on year, while most of its competitors have experienced contraction in revenues by -0.03 %, achieved in the same quarter.

• List of AGN Competitors

With a net margin of 10.51 % Allergan Plc achieved higher profitability than its competitors.

• More on AGN Profitability Comparisons

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Allergan plc achieved net profit of $379.00 millions compared to a net loss of $-2,407.30 millions recorded in the same quarter a year ago.

<< AGN Stock Performance Comparisons

<< See the full list of AGN competitors

Overall company Market Share Q1 2020

In spite of moderate revenue growth of 0.2 % within Overall company, Allergan plc improved its market share. << More on AGN Market Share.

*Market share is calculated based on total revenue.

AGN's Stock Performance relative to its Competitors

Publicly Traded Peers of Allergan plc

Cutera Inc
Share Performance

-75.15%

This Year

Cutera Inc

Profile

Cutera Inc is a medical device company that specializes in aesthetic and medical laser technologies. Their business model revolves around developing and manufacturing innovative laser systems for various medical applications including hair removal, skin rejuvenation, and vascular therapies. By selling these advanced devices to physicians, medical spas, and clinics, Cutera aims to provide effective solutions for a wide range of aesthetic and medical conditions.

More about Cutera Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1.953 mill.	$ 154.198 mill.	$ -143.710 mill.

Electrocore Inc
Share Performance

+121.75%

One Year

Electrocore Inc

Profile

Electrocore Inc operates on a business model that focuses on developing and commercializing innovative neuromodulation therapies. They utilize non-invasive vagus nerve stimulation (nVNS) to offer patients drug-free solutions for various medical conditions. The company's approach involves leveraging their understanding of the human body's electrochemical signaling system to provide targeted and effective treatments across multiple therapeutic areas.

More about Electrocore Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 107.394 mill.	$ 36.527 mill.	$ -14.770 mill.

Pmgc Holdings Inc
Share Performance

+235.56%

This Quarter

Pmgc Holdings Inc

Profile

Elevai Labs Inc operates on a subscription-based model, providing users with access to their proprietary software platform that utilizes artificial intelligence technology. The platform is designed to assist businesses in automating mundane and repetitive tasks, improving operational efficiency. Elevai Labs generates revenue through monthly or annual fees charged to their customers based on the level of usage.

More about Pmgc Holdings Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 2.209 mill.	$ 2.579 mill.	$ -13.486 mill.

Evofem Biosciences Inc
Share Performance

-3.75%

Over The Past 5 Days

Evofem Biosciences Inc

Profile

Evofem Biosciences Inc's business model focuses on the development and commercialization of innovative products in the women's sexual and reproductive health sector.

More about Evofem Biosciences Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1.058 mill.	$ 18.045 mill.	$ -15.278 mill.

Integra Lifesciences Holdings Corp
Share Performance

+11.65%

One Year

Integra Lifesciences Holdings Corp

Profile

Integra Lifesciences Holdings Corp's business model revolves around developing, manufacturing, and selling medical devices and instruments to healthcare providers.

More about Integra Lifesciences Holdings Corp's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,213.949 mill.	$ 1,647.666 mill.	$ -7.243 mill.

2 more competitors available

Sources: Allergan plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, September 14, 2026 4:01 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Allergan plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.